Impact of Medicare changes in pharmacy reimbursement on patient care: Two case reports

American Journal of Health-System Pharmacy

Volumn 64, Issue 15 SUPPL., 2007, Pages

  Siegel, Jerry ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Decision making; Economics; Ethics; Geriatrics; Health benefit programs; Laws; Medicare Prescription Drug Improvement and Modernization Act; Patient care; Pharmaceutical services; Pharmacy; Prescriptions; Quality of life; Reimbursement

Indexed keywords

ALENDRONIC ACID; CORTICOSTEROID; GLIBENCLAMIDE; IMMUNOGLOBULIN; OMEPRAZOLE; TOLTERODINE; VERAPAMIL;

AGED; CASE REPORT; CONFERENCE PAPER; DRUG COST; DRUG INDICATION; FEMALE; GERIATRIC CARE; HEALTH CARE POLICY; HEMOLYTIC ANEMIA; HUMAN; LAW; MEDICARE; OVERACTIVE BLADDER; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT;

EID: 34547409983     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070256     Document Type: Conference Paper

References (3)

1. Brill JV. Trends in the prescription drug plans delivering the Medicare Part B Prescription Drug Benefit. Am J Health-Syst Pharm. 2007: 64 (Suppl 10):S2-5.
2. Johnson PE. Changes in reimbursement rates and rules associated with the Medicare Prescription Drug Improvement and Modernization Act. Am J Health-Syst Pharm. 2006; 63 (Suppl 7):S2-6.
3. Siegel JS. Impact of the Medicare Prescription Drug Improvement and Modernization Act on the management of colorectal cancer. Am J Health-Syst Pharm. 2006; 63 (Suppl 2):S18-21.